- Home
- TLSA vs SPPP Comparison
TLSA vs SPPP Comparison
Compare TLSA & SPPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSA
- SPPP
- Stock Information
- Founded
- TLSA 2013
- SPPP 2011
- Country
- TLSA United Kingdom
- SPPP Canada
- Employees
- TLSA N/A
- SPPP N/A
- Industry
- TLSA Biotechnology: Pharmaceutical Preparations
- SPPP
- Sector
- TLSA Health Care
- SPPP
- Exchange
- TLSA Nasdaq
- SPPP NYSE
- Market Cap
- TLSA 175.3M
- SPPP 172.2M
- IPO Year
- TLSA 2000
- SPPP N/A
- Fundamental
- Price
- TLSA $1.55
- SPPP $11.28
- Analyst Decision
- TLSA
- SPPP
- Analyst Count
- TLSA 0
- SPPP 0
- Target Price
- TLSA N/A
- SPPP N/A
- AVG Volume (30 Days)
- TLSA 282.4K
- SPPP 183.3K
- Earning Date
- TLSA 07-01-2025
- SPPP 01-01-0001
- Dividend Yield
- TLSA N/A
- SPPP N/A
- EPS Growth
- TLSA N/A
- SPPP N/A
- EPS
- TLSA N/A
- SPPP N/A
- Revenue
- TLSA N/A
- SPPP N/A
- Revenue This Year
- TLSA N/A
- SPPP N/A
- Revenue Next Year
- TLSA N/A
- SPPP N/A
- P/E Ratio
- TLSA N/A
- SPPP N/A
- Revenue Growth
- TLSA N/A
- SPPP N/A
- 52 Week Low
- TLSA $0.63
- SPPP $8.55
- 52 Week High
- TLSA $1.91
- SPPP $11.39
- Technical
- Relative Strength Index (RSI)
- TLSA 59.97
- SPPP 61.09
- Support Level
- TLSA $1.35
- SPPP $11.24
- Resistance Level
- TLSA $1.67
- SPPP $11.58
- Average True Range (ATR)
- TLSA 0.10
- SPPP 0.23
- MACD
- TLSA 0.02
- SPPP 0.01
- Stochastic Oscillator
- TLSA 80.88
- SPPP 59.32
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.
About SPPP SPROTT PHYS PLATINUM & PALLADIUM
Sprott Physical Platinum & Palladium Tr invests and holds all of its assets in physical platinum and palladium bullion. The company seeks to provide a secure, convenient, and exchange-traded investment alternative for investors interested in holding physical platinum and palladium bullion without the inconvenience that is typical of a direct investment in physical bullion. The Trust invests mainly in long-term holdings of unencumbered, fully allocated, physical platinum and palladium bullion.